Héctor Gonzalo Galindo Araníbar

Oncología

Cargo

Instructor asociado

Teléfono

(+56)9 6341 3803

Contacto

hggalind@uc.cl

Ver menos

Formación Pregrado:

  • 1986 – 1993 : Medicina, Universidad Mayor de San Simón, Bolivia

Formación Postgrado:

  • 1995 – 1998: Especialidad en Medicina Interna, Pontificia Universidad Católica de Chile.

  • 1998 – 2001 : Subespecialidad en Hematología y Oncología, Pontificia Universidad Católica de Chile.

Actividades Docentes Asistenciales:

  • 2019 MED-404A CLÍNICAS III DOCENTE
  • 2019 MED-309A CLÍNICAS II DOCENTE
  • 2019 ERP-003 MED703B/Internado optativo
  • 2021 ERP003 /Ficticio curso pregrado medicina
  • 2021 ERP004 Ficticio curso medicina postítulo

Investigación y Proyectos:

  • 01-05-2010 – 19-04-2012 : Proyecto1:»Array Comparative Genomic Hibridization (aCGH)analysis of Primary Tumor Non-small Cell Lung Cancer (NSCLC)and their Corresponding Brain Metastasis:Study of molecular changes and pathogenesis»Rol:Post-doctoral fellow encargado del diseño, ejecución, analisis de datos y presentacion de los resultados.
  • 01-05-2010 – 19-04-2012 : Proyecto2:»Standarization of extraction of DNA with SPRI- TEchnology from tumor tissue of NSCLC samples(Tissue Rererence Set)from Core Needle Biopsy(CNB),Fine Needle Aspiration (FNA)Biopsy and Frozen Tissue,comparation of quality for study of mutations using MALDI-TOF MS based SNP analysis (Sequenom).

  • 01-05-2010 – 19-04-2012 : Proyecto3:»Prospect Grant:Study of molecular abnormalities of NSCLC samples treated with neoadjuvant therapy (Chemotherapy and/or Radiotherapy)».Rol:Post-doctoral fellow encargado del analisis del aCGH de 250 muestras.

  • 01-05-2010 – 19-04-2012 Proyecto4:»Multiple Primary Lung Cancer:The possibility of differentiating the origin of two tumors or two tomors or cofirm trat one is metatatic of other is based on the demonstration of clonality with molecular genetic merkers»Post-doctoral fellow encargado del diseno,ejecución, analisis de datos y presentacion de los resultados.

Publicaciones Científicas Internacionales:

  • 2020 : Maiz C ; Galindo H; Camus M; León A; Oddó D; Villarroel A; Razmilic D; Navarro ME; Medina L; Merino T; Vines E; Peña J; Maldonado D; Pinto M; Acevedo F and Sánchez C.Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution. Ecancermedicalscience 2020-01 | journal-article PMID: 32104207PMC: PMC7039691DOI: 10.3332/ecance
  • 2020 : Pizarro G; Pinto M; Muñoz M; Cordova M: Bravo ML; Nervi B; Sánchez C; Ibáñez C; Peña J; Walbaum B; Madrid J; Briones J; Koch E; Valbuena J; Gonzalez S; Gejma R; Avecedo F; Mondaca S; Garrido M; Vines E; Galindo H. Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Sm
  • 2020 : Calderillo G; Muñoz-Medel M; Carbajal E; Córdova-Delgado M; Durán D; Retamal IN; Fernández P; Espinoza A; Salas R; de la Paz Mastretta M; Galindo H; Nervi B;Madrid J; Sánchez C; Ibáñez C;Peña J; Mondaca S;Acevedo F; Koch E; Pinto MP; Garrido M.Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities. JCO global oncology 2020-04 | journal-ar
  • 2020 : Walbaun B; Acevedo F; Medina L; Bravo ML; Merino T; Camus M; Domínguez F; Mondaca S; Galindo H; Nervi B; Ibáñez C; Madrid J; Peña J; Koch E; Garrido M; Pinto M and Sánchez CFirst-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution. Current medical research and opinion 2020-04 | journal-
    article PMID: 32351137DOI: 10.1080/0300799
  • 2020 : Pinto M; Córdova M, Retamal I; Muñoz M; Bravo ML; Durán D; Villanueva F; Sánchez C; Acevedo F; Mondaca S; Koch E; Ibañez C; Galindo H; Madrid J; Nervi B; Peña J; Torres J; Garrido M. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability Cancers 2020-07 | journal-article DOI: 10.3390/cancers12071863
  • 2020 : Salas P; Solovera ME; Bannura F; Matias Muñoz M; Cordova M; Sánchez C; Ibáñez C; Garrido M; Koch E; Acevedo F; Mondaca S; Nervi B; Madrid J; Peña J; Pinto M, Valbuena J and Galindo H. Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2021.1201

Publicaciones Científicas Nacionales:

  • 2018 : Oddó D, Pulgar D, Elgueta N, Acevedo F, Razmiliz D, Navarro ME, Camus M, Merino T, Retamal I, Pérez-Sepúlveda A, Villarroel A, Galindo H, Peña J, Sánchez C.Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?.Asian Pac J Cancer Prev. 2018 Jan 27;19(1):179-183
  • 2018 : Owen GI, Pinto MP, Retamal IN, Fernádez MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibañez C, Acevedo F, Madrid J, Peña J, Bravo ML, Maturana MJ, Cordova-Delgado M, Romero D, de la Jara N, Torres J, Rodriguez-Fernandez M, Espinoza M, Balmaceda C, Freire M, Gárate-Calderón V, Crovari F, Jimenez-Fonseca P, Carmona-Bayonas A, Zwenger A, Armisen R, Corvalan AH, Garrido MChilean Gastric